Screener
Amphastar Pharmaceuticals AMPH Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $183.9M+5.4% | $171.17M+0.4% | $183.11M-1.8% | $191.84M+0.3% | $174.41M-4.4% | ||
| $90.43M+2.9% | $100.85M+18.3% | $97.44M-2.4% | $93.19M+4.4% | $87.92M+0.8% | ||
| $93.47M+8.1% | $70.32M-17.5% | $85.67M-1.1% | $98.65M-3.2% | $86.49M-9.1% | ||
| 50.8%+1.2pp | 41.1%-8.9pp | 46.8%+0.3pp | 51.4%-1.9pp | 49.6%-2.6pp | ||
| $22.16M+10.4% | $26.74M+33.0% | $23.31M+28.5% | $22.35M+6.1% | $20.08M+13.8% | ||
| $13.34M+30.3% | $11.93M+0.5% | $10.28M-1.4% | $11.51M+27.9% | $10.24M+13.6% | ||
| $18.24M+30.4% | $18.03M+12.7% | $16.47M+27.3% | $39.47M+166% | $13.99M+5.3% | ||
| $53.74M+21.3% | $56.69M+18.2% | $50.06M+20.6% | $73.33M+63.3% | $44.31M+10.9% | ||
| $39.73M-5.8% | $13.63M-63.5% | $35.61M-21.1% | $25.32M-55.6% | $42.18M-23.6% | ||
| 21.6%-2.6pp | 8%-13.9pp | 19.4%-4.8pp | 13.2%-16.6pp | 24.2%-6.1pp | ||
| $6.66M+6.0% | $6.55M+4.2% | $6.63M+3.2% | $6.28M-6.2% | $6.28M-27.0% | ||
| -$1.19M+58.4% | -$3.58M+44.4% | -$3.69M-212% | -$3.81M+59.3% | -$2.85M+42.7% | ||
| $38.54M-2.0% | $10.05M-67.4% | $31.91M-27.4% | $21.51M-54.9% | $39.34M-21.7% | ||
| $8.2M-1.3% | $3.63M-34.9% | $7.49M+24.8% | $4.16M-42.6% | $8.31M-32.4% | ||
| $30.35M-2.2% | $6.42M-74.6% | $24.43M-35.7% | $17.35M-57.1% | $31.03M-18.2% | ||
| 16.5%-1.3pp | 3.8%-11.1pp | 13.3%-7.0pp | 9%-12.1pp | 17.8%-3.0pp | ||
| $0.67+4.7% | $0.14-72.5% | $0.51-31.1% | $0.37-52.6% | $0.64-12.3% | ||
| $54.04M-4.9% | $27.98M-45.0% | $49.95M-14.7% | $39.45M-44.0% | $56.8M-16.9% | ||
| 29.4%-3.2pp | 16.3%-13.5pp | 27.3%-4.1pp | 20.6%-16.3pp | 32.6%-4.9pp | ||
| $39.73M-5.8% | $13.63M-63.5% | $35.61M-21.1% | $25.32M-55.6% | $42.18M-23.6% |
FAQ
- What is Amphastar Pharmaceuticals's revenue?
- Amphastar Pharmaceuticals (AMPH) generated $730.0M in revenue over the trailing twelve months, up 1.0% year over year.
- Is Amphastar Pharmaceuticals profitable?
- Amphastar Pharmaceuticals reported $78.5M in net income over the trailing twelve months, a 10.8% net margin.
- What are Amphastar Pharmaceuticals's profit margins?
- Gross margin is 47.7% and operating margin is 15.7%, with a 10.8% net margin.
- What is Amphastar Pharmaceuticals's earnings per share?
- Amphastar Pharmaceuticals's diluted EPS over the trailing twelve months is $1.69.
- Where does Amphastar Pharmaceuticals's income statement data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
